Sphingosine kinase type 1 inhibitors and uses thereof
US9974758B2 · kind B2 · utility
5Cited by
7References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 14, 2016 |
| Grant date | May 22, 2018 |
| Priority date | — |
| Expiry date | Jun 14, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/092
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are inhibitors of sphingosine kinase Type I that are useful in a number of applications, indications and diseases, as well as for monitoring pharmacokinetics and patient management. These compounds are applicable to treating tumors of the central nervous system, such as glioblastoma multiforme (GBM).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.